Log in
Paul Mampilly correctly predicted every bull and bear market over the last two decades. He made millions. His new "Dow 100,000" prediction is his boldest yet. Even more stunning... Paul reveals how you could make millions as it unfolds.

OTCMKTS:RBCL - RBC Life Sciences Stock Price, Forecast & News

0.00 (0.00 %)
(As of 01/24/2020 05:15 AM ET)
Today's Range
Now: $0.25
50-Day Range
MA: $0.12
52-Week Range
Now: $0.25
Volume5,000 shs
Average Volume4,323 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.

Industry, Sector and Symbol

Industry Miscellaneous nondurable goods
Current SymbolOTCMKTS:RBCL



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive RBCL News and Ratings via Email

Sign-up to receive the latest news and ratings for RBCL and its competitors with MarketBeat's FREE daily newsletter.


A Jump Trader caught a 58% gain in just ONE DAY...

Another, $2,080 in profit in just ONE DAY...

Every day you miss out on this could be costing you... $500...

$1,000... Even $2,080 a day...

RBC Life Sciences (OTCMKTS:RBCL) Frequently Asked Questions

What is RBC Life Sciences' stock symbol?

RBC Life Sciences trades on the OTCMKTS under the ticker symbol "RBCL."

Has RBC Life Sciences been receiving favorable news coverage?

News headlines about RBCL stock have trended very negative this week, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. RBC Life Sciences earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for RBC Life Sciences.

Who are some of RBC Life Sciences' key competitors?

What other stocks do shareholders of RBC Life Sciences own?

Who are RBC Life Sciences' key executives?

RBC Life Sciences' management team includes the folowing people:
  • Mr. Clinton H. Howard, Founder & Chairman (Age 90)
  • Mr. Steven E. Brown, Pres, Chief Exec. Officer & Director (Age 63)
  • Mr. Douglas R. Wheeler, VP of Operations (Age 45)
  • Mr. Don Clark, Chief Information Officer
  • Ms. Carolyn Rachaner, VP of Marketing & Product Devel.

How do I buy shares of RBC Life Sciences?

Shares of RBCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is RBC Life Sciences' stock price today?

One share of RBCL stock can currently be purchased for approximately $0.25.

What is RBC Life Sciences' official website?

The official website for RBC Life Sciences is http://www.rbclifesciences.com/.

How can I contact RBC Life Sciences?

RBC Life Sciences' mailing address is 2301 CROWN COURT, IRVING TX, 75038. The company can be reached via phone at 972-893-4000 or via email at [email protected]

MarketBeat Community Rating for RBC Life Sciences (OTCMKTS RBCL)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  41 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  89
MarketBeat's community ratings are surveys of what our community members think about RBC Life Sciences and other stocks. Vote "Outperform" if you believe RBCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RBCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel